Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080305102A1
SERIAL NO

11993774

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Inhibition of synoviolin function was found to activate the cancer-suppressing protein p53. Substances inhibiting the function of synoviolin are useful as cancer therapeutic agents. The inhibition of synoviolin function was also found to lead to the inhibition of p53 ubiquitination, increased activity of p53 phosphorylation proteins, and the like. Based on these findings, the present invention provides methods capable of efficiently screening for cancer therapeutic agents. Further, it was also found that regulation of the autoubiquitination of synoviolin protein suppresses the proliferation of rheumatoid arthritis synovial cells. Substances regulating the autoubiquitination of synoviolin protein are useful as anti-rheumatic agents. Moreover, the present invention provides methods of efficiently screening for anti-rheumatic agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ST MARIANNA UNIVERSITY SCHOOL OF MEDICINEKAWASAKI-SHI KANAGAWA 216-8511

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Amano, Tetsuya Kanagawa, JP 40 326
Kato, Yukihiro Kanagawa, JP 53 951
Nakajima, Toshihiro Kanagawa, JP 68 328
Yamadera, Tadayuki Kanagawa, JP 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation